Deirdre Finnigan: New Insights into Red Blood Cell Biomechanics in Cancer-Associated Anemia
Deirdre Finnigan, Teaching Assistant at Queen’s University, shared on LinkedIn about a recent article she and her colleagues co-authored, published in Microcirculation, adding:
”I am excited to share that our paper, ‘Evaluation of Red Blood Cell Biomechanics in the Setting of Cancer-Associated Anemia and Chemotherapy’ has been published in Microcirculation.
This paper reflects my master’s thesis work, and is my first first-authored publication.
I am incredibly grateful to my co-authors Nick Cruickshanks, George Ilbawi, Regan Bucciol, and Yousra Tera, for their contributions, and especially to my supervisor, Dr. Maha Othman MD MSc PhD, for her guidance and support on this project!
P.S. The paper is open access, so I’d love for you to give it a read!”
Title: Evaluation of Red Blood Cell Biomechanics in the Setting of Cancer-Associated Anemia and Chemotherapy
Authors: Deirdre Finnigan, Nick Cruickshanks, George Ilbawi, Regan Bucciol, Yousra Tera, Maha Othman

Stay updated on all scientific advances with Hemostasis Today.
-
Oct 9, 2026, 16:23David Boone: Distinguishing Stroke Prevention from Rhythm Control in Atrial Fibrillation
-
Oct 9, 2026, 15:27Mohamed Hegazi: Geostatistical Modelling Maps Global β-Thalassaemia Carrier Prevalence
-
Oct 9, 2026, 15:15Maha Othman: Uncovering the Consensus on TXA in TBI – Call for Collaboration on a Landmark Umbrella Review
-
Oct 9, 2026, 15:07Daniel D. Han: How Inhalation Product Exposure Impairs Cardiac and Platelet Recovery After MI
-
Oct 9, 2026, 14:58William Toole: How Ultrasound-Guided PRP Therapy Relieves Joint and Tendon Pain
-
Oct 9, 2026, 14:50Shayan Mohammadmoradi: In Corpus Christi for the 20th Midwest Platelet Conference
-
Oct 9, 2026, 14:37Tariq Tramboo: High Platelet Concentrate for Osteoarthritis Knee – Recent Meta-Analyses
-
Oct 9, 2026, 14:26Yousma Khan: Hematology Series – Beyond RBCs, WBCs and Platelets
-
Oct 9, 2026, 14:13Jesus Ardila Novoa: Why the WHO’s Historic Essential Medicines List Decision Is Just the Beginning